Active 0 6 0 6 O
uncontrolled 7 19 7 19 B-chronic_disease
infection 20 29 20 29 I-chronic_disease
, 29 30 29 30 O
including 31 40 31 40 O
known 41 46 41 46 O
history 47 54 47 54 O
of 55 57 55 57 O
HIV 58 61 58 61 B-chronic_disease
/ 61 62 61 62 O
AIDS 62 66 62 66 B-chronic_disease
or 67 69 67 69 O
hepatitis 70 79 70 79 B-chronic_disease
B 80 81 80 81 I-chronic_disease
or 82 84 82 84 I-chronic_disease
C 85 86 85 86 I-chronic_disease

Age 0 3 87 90 B-age
≥18 4 7 91 94 O
years 8 13 95 100 I-lower_bound
and 14 17 101 104 O
≤ 18 19 105 106 O
75 20 22 107 109 B-upper_bound
years 23 28 110 115 I-upper_bound
old 29 32 116 119 O

Any 0 3 120 123 O
psychological 4 17 124 137 B-chronic_disease
, 17 18 137 138 O
familial 19 27 139 147 B-chronic_disease
, 27 28 147 148 O
sociological 29 41 149 161 B-chronic_disease
, 41 42 161 162 O
or 43 45 163 165 O
geographical 46 58 166 178 B-chronic_disease
condition 59 68 179 188 I-chronic_disease
that 69 73 189 193 O
could 74 79 194 199 O
potentially 80 91 200 211 O
interfere 92 101 212 221 O
with 102 106 222 226 O
compliance 107 117 227 237 O
with 118 122 238 242 O
the 123 126 243 246 O
study 127 132 247 252 O
protocol 133 141 253 261 O
and 142 145 262 265 O
follow 146 152 266 272 O
- 152 153 272 273 O
up 153 155 273 275 O
schedule 156 164 276 284 O

Cardiac 0 7 285 292 B-clinical_variable
ejection 8 16 293 301 I-clinical_variable
fraction 17 25 302 310 I-clinical_variable
at 26 28 311 313 O
rest 29 33 314 318 O
must 34 38 319 323 O
be 39 41 324 326 O
≥ 42 43 327 328 O
40 44 46 329 331 B-lower_bound
% 46 47 331 332 I-lower_bound

Histologically 0 14 333 347 O
- 14 15 347 348 O
confirmed 15 24 348 357 O
adenocarcinoma 25 39 358 372 B-cancer
of 40 42 373 375 I-cancer
the 43 46 376 379 I-cancer
prostate 47 55 380 388 I-cancer

Performance 0 11 389 400 B-clinical_variable
status 12 18 401 407 I-clinical_variable
≤1 19 21 408 410 O

Prior 0 5 411 416 B-treatment
chemotherapy 6 18 417 429 I-treatment
( 19 20 430 431 O
docetaxel 20 29 431 440 B-treatment
, 29 30 440 441 O
cabazitaxel 31 42 442 453 B-treatment
) 42 43 453 454 O
for 44 47 455 458 O
castrate 48 56 459 467 B-cancer
resistant 57 66 468 477 I-cancer
prostate 67 75 478 486 I-cancer
cancer 76 82 487 493 I-cancer

Prior 0 5 494 499 B-treatment
docetaxel 6 15 500 509 I-treatment
( 16 17 510 511 O
≤ 17 18 511 512 O
6 19 20 513 514 B-upper_bound
cycles 21 27 515 521 I-upper_bound
) 27 28 521 522 O
as 29 31 523 525 O
first 32 37 526 531 O
line 38 42 532 536 O
therapy 43 50 537 544 B-treatment

Prior 0 5 545 550 B-treatment
therapy 6 13 551 558 I-treatment
with 14 18 559 563 O
one 19 22 564 567 O
second 23 29 568 574 O
line 30 34 575 579 O
hormonal 35 43 580 588 B-treatment
therapy 44 51 589 596 I-treatment
is 52 54 597 599 O
allowed 55 62 600 607 O
( 63 64 608 609 O
i.e. 64 68 609 613 O
bicalutamide 69 81 614 626 B-treatment
, 81 82 626 627 O
nilutamide 83 93 628 638 B-treatment
, 93 94 638 639 O
flutamide 95 104 640 649 B-treatment
, 104 105 649 650 O
ketoconazole 106 118 651 663 B-treatment
, 118 119 663 664 O
abiraterone 120 131 665 676 B-treatment
, 131 132 676 677 O
enzalutamide 133 145 678 690 B-treatment
, 145 146 690 691 O
ARN-509 147 154 692 699 B-treatment
) 154 155 699 700 O

Prior 0 5 701 706 O
treatment 6 15 707 716 B-treatment
with 16 20 717 721 O
Sipuleucel 21 31 722 732 B-treatment
- 31 32 732 733 I-treatment
T 32 33 733 734 I-treatment
, 33 34 734 735 O
radium-223 35 45 736 746 B-treatment
, 45 46 746 747 O
strontium-89 47 59 748 760 B-treatment
, 59 60 760 761 O
or 61 63 762 764 O
samarium-153 64 76 765 777 B-treatment

Screening 0 9 778 787 O
PSA 10 13 788 791 B-clinical_variable
must 14 18 792 796 O
be 19 21 797 799 O
≥ 22 23 800 801 O
1.0 24 27 802 805 B-lower_bound
ng 28 30 806 808 I-lower_bound
/ 30 31 808 809 I-lower_bound
mL 31 33 809 811 I-lower_bound

Serum 0 5 812 817 B-clinical_variable
creatinine 6 16 818 828 I-clinical_variable
within 17 23 829 835 O
normal 24 30 836 842 O
range 31 36 843 848 O

Treated 0 7 849 856 O
with 8 12 857 861 O
continuous 13 23 862 872 O
androgen 24 32 873 881 B-treatment
ablative 33 41 882 890 I-treatment
therapy 42 49 891 898 I-treatment
( 50 51 899 900 O
either 51 57 900 906 O
surgical 58 66 907 915 B-treatment
castration 67 77 916 926 I-treatment
or 78 80 927 929 O
LHRH 81 85 930 934 B-treatment
agonist 86 93 935 942 I-treatment
/ 93 94 942 943 I-treatment
antagonist 94 104 943 953 I-treatment
) 104 105 953 954 O
with 106 110 955 959 O
documented 111 121 960 970 O
castrate 122 130 971 979 B-clinical_variable
level 131 136 980 985 I-clinical_variable
of 137 139 986 988 I-clinical_variable
serum 140 145 989 994 I-clinical_variable
testosterone 146 158 995 1007 I-clinical_variable
( 159 160 1008 1009 O
< 160 161 1009 1010 O
50 161 163 1010 1012 B-upper_bound
ng 164 166 1013 1015 I-upper_bound
/ 166 167 1015 1016 I-upper_bound
dl 167 169 1016 1018 I-upper_bound
) 169 170 1018 1019 O

